Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dapagliflozin on Submaximal Exercise Tolerance in Heart Failure

NCT04956809 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT04956809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04956809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dapagliflozin on Submaximal Exercise Tolerance in Heart Failure
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
October 22, 2021
Completion date
June 1, 2023
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hfref